NCT05507853

Brief Summary

Pelvic Girdle Pain (PGP) is reported by 50% of pregnant women and up to 11 years after pregnancy, 10% of women have persistent and per definition chronic PGP. Central (nervous system) sensitization that elicits pain hypersensitivity, may be one explanation. The overall aim of this study is to explore features of central sensitization in pregnant women and its predictive ability on physical activity, functioning and health in women with PGP. Measurements of central sensitization will be done on two study groups, pregnant women with PGP and healthy controls. To identify women at risk to develop chronic pain in relation to a common pain experience ie PGP in pregnancy, may help us understand if central sensitization early in life explains why women develop chronic pain.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
144

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Aug 2023

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 31, 2022

Completed
3 months until next milestone

First Posted

Study publicly available on registry

August 19, 2022

Completed
12 months until next milestone

Study Start

First participant enrolled

August 15, 2023

Completed
1.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2025

Completed
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2025

Completed
Last Updated

April 1, 2025

Status Verified

March 1, 2025

Enrollment Period

1.9 years

First QC Date

May 31, 2022

Last Update Submit

March 31, 2025

Conditions

Outcome Measures

Primary Outcomes (2)

  • central sensitization measured by Patient Pain Drawing

    spreading of pain

    change from baseline (gestational week 20-30) at 6 weeks, at 6 months and at 12 months after delivery

  • central sensitization measured by conditioned pain modulation using an algometer and a occlusion cuff

    Malfunctioning of descending nociceptive inhibitory pathways resulting in dysfunctional endogenous analgesia, assessed by a conditioned pain modulation (CPM)= 1. PressurePainThresholds (PPT)is assed by a digital algometer at symtomatic (sacrum and lumbar paravertebral muscles and 2 remote locations)+at asymptomatic regions(web thumb-index, prox 1/3 calf ) 2. mechanism of CPM will be induced by inflating an occlusion cuff (conditioning stimulus) at the participant's left arm to a painful intensity. The occlusion cuff is inflated until 'the first sensation of pain' is reported. This cuff inflation is maintained for 30 sec. The participant is than asked to rate the pain intensity, as a result of cuff inflation at the left arm, on a NRS (0=no pain-10=worst pain). Next, the cuff inflation is increased or decreased until pain intensity at the left arm was rated as 3/10 on NRS. The PPT assessments are then repeated during maintenance of the cuff inflation and relaxation of the left arm.

    change from baseline (gestational week 20-30) at 6 weeks, at 6 months and at 12 months after delivery

Secondary Outcomes (8)

  • Pregnancy Physical Activity Questionnaire

    change from baseline (gestational week 20-30) at 6 weeks, at 6 months and at 12 months after delivery

  • Pelvic Girdle Questionnaire

    change from baseline (gestational week 20-30) at 6 weeks, at 6 months and at 12 months after delivery

  • Patients Specific Functioning Scale

    change from baseline (gestational week 20-30) at 6 weeks, at 6 months and at 12 months after delivery

  • EuroQol 5-dimension questionnaire (EQ5D)

    change from baseline (gestational week 20-30) at 6 weeks, at 6 months and at 12 months after delivery

  • Work Ability Index

    change from baseline (gestational week 20-30),at 12 months after delivery,

  • +3 more secondary outcomes

Other Outcomes (3)

  • Fear-Avoidance Beliefs Questionnaire subscale on physical activity (FABQ-PA)

    change from baseline (gestational week 20-30) at 6 weeks, at 6 months and at 12 months after delivery

  • subscale Catastrophizing (CSQ-CAT),from the Coping Strategies Questionnaire

    change from baseline (gestational week 20-30) at 6 weeks, at 6 months and at 12 months after delivery

  • General Self-Efficacy Scale

    change from baseline (gestational week 20-30) at 6 weeks, at 6 months and at 12 months after delivery

Eligibility Criteria

Age18 Years+
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

pregnant women at maternity care units and social media

You may qualify if:

  • pregnant (first time pregnant or previous experience of pregnancy)
  • years of age or older
  • have a single foetus pregnancy
  • be in gestational weeks 20-30
  • able to read and understand Swedish or English

You may not qualify if:

  • no history of a fracture or malignant disease in the back, pelvis, pelvic floor or hips
  • no systemic disease of the musculoskeletal or the nervous system
  • no diseases such as gestational diabetes or diabetes type 1 and 2, hypertension
  • no obstetric complications
  • no contradiction for tests.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Närhälsan Gibraltargatan

Gothenburg, 43654, Sweden

RECRUITING

MeSH Terms

Conditions

Pelvic Girdle PainChronic Pain

Condition Hierarchy (Ancestors)

Musculoskeletal PainPainNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and SymptomsPelvic Pain

Central Study Contacts

Annelie Gutke, associate professor

CONTACT

Sonia Coelho Cristovao, PhD-student

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 31, 2022

First Posted

August 19, 2022

Study Start

August 15, 2023

Primary Completion

July 1, 2025

Study Completion

December 31, 2025

Last Updated

April 1, 2025

Record last verified: 2025-03

Locations